Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Cervical Cancer

  Free Subscription


04.08.2025

1 Afr J Reprod Health
1 Am J Obstet Gynecol
1 Ann Epidemiol
1 Arch Gynecol Obstet
1 Arch Med Sci
3 Asian Pac J Cancer Prev
1 Biochem Biophys Rep
1 Bioengineering (Basel)
1 Biomedicines
1 Biosens Bioelectron
1 BJOG
1 BMC Cancer
3 BMC Public Health
1 BMC Res Notes
2 BMC Womens Health
1 BMJ Open
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Med
1 Cancer Prev Res (Phila)
1 Cell Death Dis
1 Cell Oncol (Dordr)
1 Clinics (Sao Paulo)
1 Curr Pharm Biotechnol
1 Discov Oncol
1 Eur J Obstet Gynecol Reprod Biol
1 Eur J Public Health
1 Expert Opin Biol Ther
1 Food Chem Toxicol
1 Front Cell Infect Microbiol
1 Front Immunol
1 Gac Med Mex
1 Gynecol Oncol Rep
1 Health Equity
1 Health Expect
1 Health Policy Plan
2 Int J Environ Res Public Health
1 Int J Epidemiol
2 Int J Gynaecol Obstet
1 Int J Gynecol Cancer
1 Int J Mol Sci
1 Int J Surg
1 J Cancer Educ
1 J Health Organ Manag
2 J Obstet Gynaecol Res
1 Lab Invest
1 Lancet Infect Dis
1 Lancet Public Health
1 Medicine (Baltimore)
1 Neoplasia
2 Nucleosides Nucleotides Nucleic Acids
1 Pathogens
1 Pharmaceuticals (Basel)
1 Pharmaceutics
1 PLOS Glob Public Health
1 PLoS One
1 Prev Med
1 Prog Community Health Partnersh
1 Reports (MDPI)
1 Reprod Health
3 Sci Rep
1 Spectrochim Acta A Mol Biomol Spectrosc
1 Ther Adv Med Oncol
1 Ther Adv Vaccines Immunother
1 Tumori
1 Virol J
1 Viruses


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Afr J Reprod Health

  1. LI Y, Wang H, Yang J, Wang H, et al
    Triage accuracy of a six-gene methylation detection for high-risk HPV-positive Chinese women.
    Afr J Reprod Health. 2025;29:137-147.
    PubMed         Abstract available


    Am J Obstet Gynecol

  2. LEVIN G, Monk BJ, Pothuri B, Coleman R, et al
    Racial and ethnic enrollment disparities in clinical trials leading to FDA approvals for gynecologic malignancies.
    Am J Obstet Gynecol. 2025 Jan 23:S0002-9378(25)00048.
    PubMed         Abstract available


    Ann Epidemiol

  3. MA Z, Liu M, Yuan Q, Tang Z, et al
    Differences in Cervical Cancer Stage at Diagnosis and Survival Outcomes Among Asian, Native Hawaiian, and Other Pacific Islander Patients and White Patients.
    Ann Epidemiol. 2025 Jul 23:S1047-2797(25)00209.
    PubMed         Abstract available


    Arch Gynecol Obstet

  4. MARTIN TM, Castro CC, Glickman A, Carreras N, et al
    Sentinel lymph node biopsy versus pelvic lymphadenectomy for early-stage cervical cancer: a retrospective institutional review.
    Arch Gynecol Obstet. 2025 Jul 31. doi: 10.1007/s00404-025-08134.
    PubMed         Abstract available


    Arch Med Sci

  5. RZYMSKA A, Kycler W, Muszynska M, Rzymski P, et al
    Limited confidence in cervical cancer screening - unusually increased carcinoembryonic antigen expression resulting in the rapid development of cervical intraepithelial neoplasia grade 2.
    Arch Med Sci. 2025;21:1073-1076.
    PubMed        


    Asian Pac J Cancer Prev

  6. SALIH SR, Abdulla KN, K Awn A, Yasin YS, et al
    Impact of Esomeprazole, Ciprofloxacin and Their Combination on Cervical Cancer Cell Line Proliferation: A Focus on Heat Shock Protein 70 Modulation.
    Asian Pac J Cancer Prev. 2025;26:2455-2466.
    PubMed         Abstract available

  7. IROWA O, Adeyeye OS, Ogwuche PE, Otache AE, et al
    Knowledge Attitude and Determinants of Cervical Cancer Screening Uptake Among Age-Eligible Women and Male Partners in Makurdi North-Central Nigeria.
    Asian Pac J Cancer Prev. 2025;26:2389-2396.
    PubMed         Abstract available

  8. DOGAN NU, Dogan S
    New Surgical Techniques for Early Stage Cervical Cancer Under 2 cm : Is There Enough Evidence?
    Asian Pac J Cancer Prev. 2025;26:2319-2325.
    PubMed         Abstract available


    Biochem Biophys Rep

  9. JIAO L, Gao Y
    miR-21-5p inhibitor enhances the radiosensitivity of human cervical cancer cells via blocking CPEB3-mediated CDK1/cyclin B pathway.
    Biochem Biophys Rep. 2025;43:102177.
    PubMed         Abstract available


    Bioengineering (Basel)

  10. GIANSANTI D, Lastrucci A, Pirrera A, Villani S, et al
    AI in Cervical Cancer Cytology Diagnostics: A Narrative Review of Cutting-Edge Studies.
    Bioengineering (Basel). 2025;12:769.
    PubMed         Abstract available


    Biomedicines

  11. MERDZHANOVA-GARGOVA Y, Ivanova M, Mollova-Kysebekirova A, Mihaylova A, et al
    Advancements in Cervical Cancer Screening: Enhancing HPV Testing and Triage Strategies for Improved Risk Assessment.
    Biomedicines. 2025;13:1768.
    PubMed         Abstract available


    Biosens Bioelectron

  12. LONG Y, Yu T, Shi D, Song L, et al
    T7-assisted special rolling circular amplification platform for point-of-care cervical cancer screening.
    Biosens Bioelectron. 2025;288:117831.
    PubMed         Abstract available


    BJOG

  13. ELLIS LB, Bowden SJ, Lyons D, Kyrgiou M, et al
    SIP 7: Progress in Cervical Cancer Prevention in the UK (2025 Second Edition).
    BJOG. 2025 Jul 30. doi: 10.1111/1471-0528.18262.
    PubMed         Abstract available


    BMC Cancer

  14. YAO X, Qie M, Kang L, Li M, et al
    Assessing the risk of undetected cervical cancer in women with a biopsy of high-grade cervical intraepithelial neoplasia: predictive value of cytology and endocervical curettage (ECC).
    BMC Cancer. 2025;25:1238.
    PubMed         Abstract available


    BMC Public Health

  15. SULTANOV M, de Bock GH, Koot JAR, de Zeeuw J, et al
    High-risk human papillomavirus testing for underscreened populations: cost-effectiveness and affordability in three country settings.
    BMC Public Health. 2025;25:2570.
    PubMed         Abstract available

  16. YESILFIDAN D, Ozkan M, Adana F
    Comparison of cervical Cancer-Related knowledge, attitudes, and behaviors among women in urban and rural regions.
    BMC Public Health. 2025;25:2561.
    PubMed         Abstract available

  17. CHAPOLA JC, Chinula L, Dunda W, Bula A, et al
    Exploring perceived barriers and facilitators to using mobile phone technology for delivering HPV test results in malawi: a qualitative study with HPV-Screened women, healthcare providers, and health officials.
    BMC Public Health. 2025;25:2563.
    PubMed         Abstract available


    BMC Res Notes

  18. BAZMI H, Asghari AA, Jalali MB, Rezvan L, et al
    Upregulation of PCAT1, PCAT2, and PCAT3 LncRNAs in cervical cancer patients and their diagnostic value.
    BMC Res Notes. 2025;18:326.
    PubMed         Abstract available


    BMC Womens Health

  19. WANG ZT, Dang CW, You RL, Li S, et al
    Age-period-cohort analysis of global, regional, and national cervical cancer prevalence trends in women of childbearing age (15-49 years), 1990-2021.
    BMC Womens Health. 2025;25:374.
    PubMed         Abstract available

  20. NIE F, Si H, Qin H, Wang Y, et al
    Cervical and vaginal metastases from ascending colon cancer: a case report and literature review.
    BMC Womens Health. 2025;25:369.
    PubMed         Abstract available


    BMJ Open

  21. DESTAW A, Getachew S, Getachew E, Shita A, et al
    Follow-up rescreening uptake and persistent positive rates among women after positive cervical cancer screening results in Ethiopia: a longitudinal cross-sectional study.
    BMJ Open. 2025;15:e099955.
    PubMed         Abstract available


    Cancer Epidemiol Biomarkers Prev

  22. HUDDLESTON C, Mani C, Sah N, Courtney E, et al
    Evaluating Efficacy of Cervical HPV-HR DNA Testing as Alternative to PET/CT Imaging for Posttreatment Cancer Surveillance: Retrospective Proof-of-Concept Study.
    Cancer Epidemiol Biomarkers Prev. 2025;34:1264-1268.
    PubMed         Abstract available


    Cancer Med

  23. NIU J, Sasidharan S
    Development of a Mitochondrial Permeability Transition-Driven Necrosis-Related Prognostic Signature in Cervical Cancer: Integrating Bulk Transcriptomic and Single-Cell Data.
    Cancer Med. 2025;14:e71094.
    PubMed         Abstract available


    Cancer Prev Res (Phila)

  24. LI Y, Qin C, Li KT, He Y, et al
    Feasibility and Acceptability of Pay-it-forward in Increasing Uptake of HPV Vaccination among 15- to 18-Year-Old Girls in China: Pilot RCT Results.
    Cancer Prev Res (Phila). 2025;18:485-492.
    PubMed         Abstract available


    Cell Death Dis

  25. SUN Q, Yang Z, Li P, Wang X, et al
    Retraction Note to: A novel miRNA identified in GRSF1 complex drives the metastasis via the PIK3R3/AKT/NF-kappaB and TIMP3/MMP9 pathways in cervical cancer cells.
    Cell Death Dis. 2025;16:569.
    PubMed        


    Cell Oncol (Dordr)

  26. WANG S, Mao Z, Liu Y, Lan C, et al
    Apo10 and TKTL1 in blood macrophages as non-invasive biomarkers for early detection of cervical cancer.
    Cell Oncol (Dordr). 2025 Jul 28. doi: 10.1007/s13402-025-01092.
    PubMed         Abstract available


    Clinics (Sao Paulo)

  27. ARAI RJ, da Costa TR, Bonadio RC, Ferreira S, et al
    Exploratory unsupervised machine learning of angiogenesis biomarkers in a phase II advanced cervical cancer trial of radiochemotherapy with or without neoadjuvant chemotherapy.
    Clinics (Sao Paulo). 2025;80:100723.
    PubMed         Abstract available


    Curr Pharm Biotechnol

  28. SHARMA S, Mishra A, Pandey P, Verma M, et al
    Emerging Protein Therapeutics as a Strategy for Cervical Cancer Treatment.
    Curr Pharm Biotechnol. 2025 Jul 25. doi: 10.2174/0113892010397753250704105423.
    PubMed         Abstract available


    Discov Oncol

  29. CAI Y, Jiang N, Wang Y, Ji M, et al
    Association and interaction network analysis of immune cell subgroups in cervical cancer microenvironment based on Mendelian randomization.
    Discov Oncol. 2025;16:1412.
    PubMed         Abstract available


    Eur J Obstet Gynecol Reprod Biol

  30. FERREIRA MCP, Sebastiao APM, Zanine RM
    The risk of recurrence of high-grade squamous intraepithelial lesions and its association with the number of colposcopic biopsies.
    Eur J Obstet Gynecol Reprod Biol. 2025;312:114554.
    PubMed         Abstract available


    Eur J Public Health

  31. PEREIRA SDG, Nobre L, Ribeiro M, Carvalho P, et al
    Targeting under-screened women in cervical cancer: combining self-sampling and human papillomavirus testing with a strategic reminder plan.
    Eur J Public Health. 2025 Jul 28:ckaf122. doi: 10.1093.
    PubMed         Abstract available


    Expert Opin Biol Ther

  32. NISHIO S
    Bintrafusp alfa and its unsuccessful development journey towards cervical cancer treatment.
    Expert Opin Biol Ther. 2025 Jul 30:1-3. doi: 10.1080/14712598.2025.2541795.
    PubMed        


    Food Chem Toxicol

  33. LI W, Wang M, Du P, Han A, et al
    CDDO-Me triggers ROS-dependent ferroptosis and apoptosis in cervical cancer via targeting PI3K/Nrf2 pathway.
    Food Chem Toxicol. 2025;204:115664.
    PubMed         Abstract available


    Front Cell Infect Microbiol

  34. KAWASAKI R, Kukimoto I, Nishio E, Otani S, et al
    Distinct cervical microbiome and metabolite profiles before and after menopause: implications for cervical cancer progression.
    Front Cell Infect Microbiol. 2025;15:1589277.
    PubMed         Abstract available


    Front Immunol

  35. CHEN J, Yu H, Lin Y, Hu D, et al
    Real-world data of cadonilimab in recurrent or metastatic cervical cancer in China: a multicentric study.
    Front Immunol. 2025;16:1611696.
    PubMed         Abstract available


    Gac Med Mex

  36. MARTINEZ-CASTILLO MA, Cueto MAH, Taniguchi-Ponciano K, Salcedo M, et al
    RET could act as suppressor tumor gene in cervical cancer cells.
    Gac Med Mex. 2025;161:132-139.
    PubMed         Abstract available


    Gynecol Oncol Rep

  37. KERNELL CG, Kassick M, George JM, Anakwenze CP, et al
    Assessing delays in accessing and completing radiotherapy for cervical cancer treatment: A multicenter survey of oncology providers in go further-funded countries in Sub-Saharan Africa.
    Gynecol Oncol Rep. 2025;60:101810.
    PubMed         Abstract available


    Health Equity

  38. SINGH S, Mehta N, Noh M, Bond K, et al
    Weight-Based Health Care Discrimination and Cervical Cancer Screening Among Black Sexual and Gender Minoritized Assigned Female at Birth Adults in the United States.
    Health Equity. 2025;9:22-30.
    PubMed         Abstract available


    Health Expect

  39. WHITLEY S, Hawkins RL, Davies JC, Cao J, et al
    Acceptability of Self-Sampling for Cervical Screening in Ethnically Diverse Groups in Northwest England: A Focus Group Study.
    Health Expect. 2025;28:e70338.
    PubMed         Abstract available


    Health Policy Plan

  40. OKOLIE EA, Beek K, Patel B, Ndikom CM, et al
    Cervical Cancer Prevention and Control in Nigeria: Mapping and review of policies.
    Health Policy Plan. 2025 Jul 30:czaf049. doi: 10.1093.
    PubMed         Abstract available


    Int J Environ Res Public Health

  41. QUINTANA GR, Herrera N, Santibanez-Palma JF, Escudero-Pasten J, et al
    Psychometric Evidence of the Pap Smear Test and Cervical Cancer Beliefs Scale (CPC-28) in Aymara Women from Chile.
    Int J Environ Res Public Health. 2025;22:1025.
    PubMed         Abstract available

  42. MBONA SV, Ananth A, Chifurira R
    A Bayesian Logistic Regression Approach to Investigating the Determinants Associated with Never Having Been Screened for Cervical Cancer Amongst Child-Bearing-Age Women in Jordan.
    Int J Environ Res Public Health. 2025;22:1000.
    PubMed         Abstract available


    Int J Epidemiol

  43. LOFLING LL, Stoer NC, Botteri E, Fortner RT, et al
    Statins and the risk of gynecological cancer: a Norwegian population-based cohort study.
    Int J Epidemiol. 2025;54:dyaf133.
    PubMed         Abstract available


    Int J Gynaecol Obstet

  44. MORA-SOTO N, Morante-Caicedo C, Caicedo-Martinez M, Viveros-Carreno D, et al
    Morbidity of radical surgery and postoperative radiotherapy in cervical cancer.
    Int J Gynaecol Obstet. 2025 Jul 30. doi: 10.1002/ijgo.70281.
    PubMed         Abstract available

  45. LI Z, Wang P, Lu D, Ding Z, et al
    Development and validation of a risk prediction model for lower limb lymphedema in postoperative cervical cancer patients.
    Int J Gynaecol Obstet. 2025 Jul 30. doi: 10.1002/ijgo.70423.
    PubMed         Abstract available


    Int J Gynecol Cancer

  46. HAGEN KK, Lie AK, Dahl GF, Eyjolfsdottir B, et al
    The Silva pattern-based classification and oncological outcomes in women undergoing fertility-sparing surgery for early-stage cervical cancer.
    Int J Gynecol Cancer. 2025;35:102012.
    PubMed         Abstract available


    Int J Mol Sci

  47. AGNANTI E, Tsakogiannis D, Papadopoulos T, Arvanitidis KI, et al
    Disruption Events in the HPV18 E1 and E2 Genes in Precancerous Cervical Lesions.
    Int J Mol Sci. 2025;26:6974.
    PubMed         Abstract available


    Int J Surg

  48. SONG T, Chen X, Chen F, Wan Q, et al
    Unraveling the prognostic puzzle: in-depth exploration of lymph node metrics for surgically treated FIGO stage IB-IIA cervical cancer-focus on the number of positive lymph nodes and the lymph node ratio.
    Int J Surg. 2025 Jul 15. doi: 10.1097/JS9.0000000000003033.
    PubMed         Abstract available


    J Cancer Educ

  49. LI D, Zhang W, Stinson J, Jibb L, et al
    Navigating HPV Vaccination: a Qualitative Study on Chinese Women's Decision-Making Experiences.
    J Cancer Educ. 2025;40:616-625.
    PubMed         Abstract available


    J Health Organ Manag

  50. KIRAN S, Akbolat M
    Perceived barriers and facilitators in access to breast and cervical cancer screening: a qualitative exploration among women in Trabzon, Turkey.
    J Health Organ Manag. 2025 Aug 1:1-17. doi: 10.1108/JHOM-12-2024-0503.
    PubMed         Abstract available


    J Obstet Gynaecol Res

  51. MIZUTA Y, Yamanoi K, Miyamoto T, Mizuno R, et al
    Therapeutic impact of neoadjuvant chemotherapy on lymph node metastasis in locally advanced cervical cancer.
    J Obstet Gynaecol Res. 2025;51:e70022.
    PubMed         Abstract available

  52. KITAJIMA K
    Updates and advances for gynecologic imaging.
    J Obstet Gynaecol Res. 2025;51:e70025.
    PubMed         Abstract available


    Lab Invest

  53. GUO A, Yu Y, Guo Q, Zhang E, et al
    Potential Role of PARVB in Macrophage-Mediated Immunosuppression and Cervical Cancer Progression.
    Lab Invest. 2025 Jul 29:104223. doi: 10.1016/j.labinv.2025.104223.
    PubMed         Abstract available


    Lancet Infect Dis

  54. AGBENYEGA T, Schuind AE, Adjei S, Antony K, et al
    Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9-14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trial.
    Lancet Infect Dis. 2025;25:861-872.
    PubMed         Abstract available


    Lancet Public Health

  55. IWAMI M, Bouaddi O, Razai MS, Mansour R, et al
    Drivers of human papillomavirus vaccine uptake in migrant populations and interventions to improve coverage: a systematic review and meta-analysis.
    Lancet Public Health. 2025;10:e693-e711.
    PubMed         Abstract available


    Medicine (Baltimore)

  56. HU S, Li Y, Hu M, Wang Z, et al
    Risk factors for hrHPV infection with cervical lesions patient in Anhui Province of China from 2021 to 2024: A retrospective study.
    Medicine (Baltimore). 2025;104:e43384.
    PubMed         Abstract available


    Neoplasia

  57. ZHOU Q, Yu H, Dong A, Yi J, et al
    The TRIM22-CDT2 axis is the key mediator of the p53-Rb signals in growth control of HPV-positive cervical carcinoma cells.
    Neoplasia. 2025;67:101211.
    PubMed         Abstract available


    Nucleosides Nucleotides Nucleic Acids

  58. ZHANG S, Shen X, Cui H
    Regulation of prognosis and tumor progression in cervical cancer by circ_0005728.
    Nucleosides Nucleotides Nucleic Acids. 2025.
    PubMed         Abstract available

  59. WANG S, Wang J, Wang K
    LncRNA PCED1B-AS1 facilitates cervical cancer progression via targeting miR-361-3p.
    Nucleosides Nucleotides Nucleic Acids. 2025.
    PubMed         Abstract available


    Pathogens

  60. GIANNELLA L, Grelloni C, Natalini L, Sartini G, et al
    Molecular Features of HPV-Independent Cervical Cancers.
    Pathogens. 2025;14:668.
    PubMed         Abstract available


    Pharmaceuticals (Basel)

  61. NITTAYABOON K, Molika P, Bissanum R, Leetanaporn K, et al
    Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Modulate Chemoradiotherapy Response in Cervical Cancer Spheroids.
    Pharmaceuticals (Basel). 2025;18:1050.
    PubMed         Abstract available


    Pharmaceutics

  62. LI J, Asat R, Li W, Parhat P, et al
    Molecular Target Identification of Gossypol Against Cervical Cancer Based on Target Fishing Technology.
    Pharmaceutics. 2025;17:861.
    PubMed         Abstract available


    PLOS Glob Public Health

  63. MOHAMMED GEBABA E, Aweke GT, Addissie A, Assefa M, et al
    Factors affecting cervical cancer knowledge among women in Addis Ababa, Ethiopia: A population-based study.
    PLOS Glob Public Health. 2025;5:e0004961.
    PubMed         Abstract available


    PLoS One

  64. MREMA A, Ngoma M, Lugina EL, Kahakwa A, et al
    Genotype distribution of human papillomavirus among women with cervical cancer stratified by HIV status in Tanzania.
    PLoS One. 2025;20:e0322311.
    PubMed         Abstract available


    Prev Med

  65. BEGLARYAN H, Khattar J, Kassee C, Barrett K, et al
    Disability and receipt of the Papanicolaou test for cervical cancer screening: A systematic review and meta-analysis.
    Prev Med. 2025;199:108376.
    PubMed         Abstract available


    Prog Community Health Partnersh

  66. STITES S, Kelly P, Glenn J, Smith S, et al
    Community-Engaged Research Informing Upstream Determinants of Cancer Prevention for People with Criminal Legal System Involvement.
    Prog Community Health Partnersh. 2025;19:227-235.
    PubMed         Abstract available


    Reports (MDPI)

  67. HITOVA-TOPKAROVA D, Payakova V, Yordanov A, Kostova-Lefterova D, et al
    Locally Advanced Cervical Cancer in a Patient with Epidermolysis Bullosa Treated with Concurrent Chemoradiotherapy and Electronic Brachytherapy.
    Reports (MDPI). 2025;8:12.
    PubMed         Abstract available


    Reprod Health

  68. LEBLANC ME, Line EC, Potter J, Goldman RE, et al
    Advancing equity in cervical cancer screening for sexual and gender minoritized people assigned female at birth (SGM AFAB) in the United States: recommendations from healthcare equity leaders.
    Reprod Health. 2025;22:135.
    PubMed         Abstract available


    Sci Rep

  69. LIU J, Zhong M, Yang K, Wang J, et al
    Proteomics analysis reveals FEN1 as a promising therapeutic target against small cell neuroendocrine carcinoma of the cervix.
    Sci Rep. 2025;15:27827.
    PubMed         Abstract available

  70. LAHDHIRI A, Benzina B, Ennaifer E, Tounsi H, et al
    HPV DNA screening and vaccination strategies in Tunisia.
    Sci Rep. 2025;15:27916.
    PubMed         Abstract available

  71. LIU M, Luo Y, Song X, Mo R, et al
    Caerin 1.1/1.9 interfere KHDRBS1-DDX5 regulatory axis to induce IL-18 mediated pyroptosis in a HeLa cell tumour model.
    Sci Rep. 2025;15:27866.
    PubMed         Abstract available


    Spectrochim Acta A Mol Biomol Spectrosc

  72. CHEN B, Yao X, Zhang S, Hu X, et al
    Highly sensitive detection of cervical cancer biomarker miR-21 using surface-enhanced Raman scattering (SERS).
    Spectrochim Acta A Mol Biomol Spectrosc. 2025;344.
    PubMed         Abstract available


    Ther Adv Med Oncol

  73. WANG Z, Chu R, Wu N, Yuan M, et al
    Development and validation of prognostic prediction models for early-stage cervical cancer patients based on pathological intermediate-risk factors.
    Ther Adv Med Oncol. 2025;17:17588359251359461.
    PubMed         Abstract available


    Ther Adv Vaccines Immunother

  74. HAMID MKI, Hasneen S, Lima AK, Shawon SR, et al
    Cervical cancer trends, HPV vaccine utilization, and screening in low- and lower-middle-income countries: an updated review.
    Ther Adv Vaccines Immunother. 2025;13:25151355251356646.
    PubMed         Abstract available


    Tumori

  75. GUO X, Wang M, Yan S, Hu K, et al
    Clinicopathological characteristics and prognosis of cervical adenocarcinoma across diverse histological subtypes.
    Tumori. 2025;111:331-348.
    PubMed         Abstract available


    Virol J

  76. SADEGHI Z, Aboofazeli A, Sarrafzadeh S, Tayebi N, et al
    Investigating the link between HPV genotypes and cervical abnormality incidence in women with HPV infections: insights from a leading referral centre.
    Virol J. 2025;22:264.
    PubMed         Abstract available


    Viruses

  77. SCHICHL K, Doorbar J
    Regulation and Deregulation of Viral Gene Expression During High-Risk HPV Infection.
    Viruses. 2025;17:937.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.